The Latest

• January 18, 2022

  By Charleston Lim

  Unilever Facing Growing Investor Backlash Over GSK Bid

  Unilever is facing increased investors backlash from both sides following reports of its $95 billion bid to acquire GSK's consumer health unit.

  

  Unilever is facing increased investors backlash from both sides following reports of its $95 billion bid to acquire GSK's consumer health unit.